Nationwide cohort study suggests that nucleos(t)ide analogue therapy decreases dialysis risk in Taiwanese chronic kidney disease patients acquiring hepatitis B virus infection

doi:10.3748/wjg.v24.i8.917

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7104)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

465

HTML

3639

Figures (1-3)

330

Tables (1-5)

270

Sum=4704

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1008

Download

1392

Sum=2400

Feb 28, 2018 (publication date) through Jan 6, 2025

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Feb 28, 2018; 24(8): 917-928
Published online Feb 28, 2018. doi: 10.3748/wjg.v24.i8.917

Full Size Figure Download Figure

Figure 2 Cumulative incidence of end-stage renal disease after adjustment for competing mortality among (A) propensity score-matched chronic kidney disease cohort and (B) propensity score-matched hepatitis B virus cohort. ESRD: End-stage renal disease.

Citation: Chen YC, Li CY, Tsai SJ, Chen YC. Nationwide cohort study suggests that nucleos(t)ide analogue therapy decreases dialysis risk in Taiwanese chronic kidney disease patients acquiring hepatitis B virus infection. World J Gastroenterol 2018; 24(8): 917-928
URL: https://www.wjgnet.com/1007-9327/full/v24/i8/917.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i8.917